Fig. 12From: Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacyImmunohistochemistry validation of PTPN3 in pan-cancer by clinical samples. A Breast cancer. B LUAD. C KIRC. D Sarcoma. E Immunohistochemistry scores of each cancerBack to article page